Physician profile
Gerhard E Maale
NPI 1689677940
$982,933.07
in general payments reported to CMS, 2019-2025
37 companies · $6,676 in 2025
The $6,676 reported for 2025 was more than what 85% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $267K · 2020: $227K · 2021: $310K · 2022: $164K · 2023: $4,170 · 2024: $3,885 · 2025: $6,676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,365 · Consulting Fee: $5,185 · Royalty Or License: $2,215 · Travel and Lodging: $1,966.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,364.59 |
| Consulting Fee | $5,184.75 |
| Royalty Or License | $2,215.35 |
| Travel and Lodging | $1,965.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $758,911.45 | 2019-2025 | Pico 14, Grafix Pl, Oasis |
| Biocomposites INC | $112,846.94 | 2020-2025 | Stimulan |
| Linkbio Corp | $52,241.02 | 2019-2024 | |
| Daiichi Sankyo INC. | $35,962.05 | 2019-2022 | |
| Onkos Surgical, INC. | $14,291.48 | 2021-2025 | Eleos Limb Salvage System |
| Bone Support INC. | $3,767.63 | 2019-2024 | Ceramentbone Void Filler, Cerament G |
| Stryker Corporation | $1,199.71 | 2019-2020 | |
| Acera Surgical, INC. | $543.13 | 2019-2024 | Restrata Wound Matrix |
| Next Science LLC | $509.93 | 2023-2024 | Xperience, Blastx, Surgx |
| Aesculap Implant Systems, LLC | $432.14 | 2019-2020 | |
| Kerecis Limited | $290.48 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $236.43 | 2022-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Davol INC. | $229.50 | 2021-2022 | |
| Sanara Medtech INC. | $200.18 | 2020 | |
| Zimmer Biomet Holdings, INC. | $200.13 | 2019 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $162.67 | 2019 | |
| Maxx Orthopedics, INC. | $104.27 | 2023 | |
| Heraeus Medical, LLC. | $102.37 | 2025 | |
| Fx Shoulder Solutions, INC | $85.16 | 2024 | |
| Resmed Corp | $77.56 | 2021-2023 | |
| G21 Srl | $75.15 | 2024 | |
| Ossur Americas, INC. | $74.38 | 2024-2025 | |
| Total Joint Orthopedics, INC. | $52.58 | 2025 | |
| Carbofix Orthopedics INC | $48.90 | 2022 | |
| Deciphera Pharmaceuticals INC. | $47.49 | 2025 | Romvimza |
| Epizyme, INC. | $35.82 | 2022 | |
| Reprise Biomedical, INC. | $34.90 | 2022 | |
| Polynovo North America LLC | $23.30 | 2025 | Novosorb Btm |
| Tela Bio, INC. | $22.61 | 2024 | Ovitex 2s |
| Solventum Corporation | $22.24 | 2024 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Biomerieux INC | $15.49 | 2023 | Biofire Blood Culture Identification 2 (Bcid2) Panel |
| Ethicon US, LLC | $15.46 | 2025 | Stratafix, Vistaseal, Dermabond Prineo |
| Tactile Systems Technology INC | $15.37 | 2024 | Flexitouch Plus, Entre Plus |
| Kci USA, INC. | $14.91 | 2023 | Prevena, Activ.A.C. |
| Orthofix Medical, INC. | $14.27 | 2022 | |
| Medtronic, INC. | $14.08 | 2021 | |
| Acell, INC. | $11.89 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$60,000.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerhard Maale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.